News - Helio Genomics
See what we're up to
in the news.

Stay up to date with how Helio is transforming the paradigm of early cancer detection.

Helio Genomics background image

Hot off the press

Read our latest stories from the newsroom.

Background Image for carousel
Health Tech: Shu Li On How Helio Health’s Technology Can Make An Important Impact On Our Overall Wellness
June 10, 2022
Background Image for carousel
Helio Genomics honored with second consecutive MedTech Breakthrough Award as “Best New Biopsy Technology Solution
May 05, 2022

Be in the loop

Stay on top of the latest Helio happenings and see our latest press releases.

The American Medical Association Approves a New Category I CPT® Code for the HelioLiver™ Test

/PRNewswire/ -- Helio Genomics ("Helio"), and its commercial partner, Fulgent Genetics (NASDAQ: FLGT) ("Fulgent") announced that the American Medical...

July 05, 2022

HelioLiver™, an Innovative Liquid Biopsy Test for the Early Detection of Liver Cancer, is Now Commercially Available

Helio Genomics and its commercial partner, Fulgent Genetics, Inc. (NASDAQ: FLGT), today announced the commercial launch of HelioLiver™, a multi-analyte blood test that incorporates...

December 06, 2021
Let’s advance cancer research—together
Helio is looking to partner with research and clinical organizations that see patients that have cancer or are at high-risk for developing cancer.
Leave us a message if you are interested in collaborating with us on upcoming clinical trials and research.
Helio Genomics ribbon
Need More Info?
We’re happy to hear from you and answer any questions you have about Helio.